west china medical publishers
Keyword
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Keyword "视神经疾病/治疗" 6 results
  • 自身免疫性视神经病变

      自身免疫性视神经病变(AON)是指通过炎症性自身免疫机制损害一侧或双侧视神经而不伴有全身性自身免疫性疾病的一种排除诊断。患者一旦出现非典型的复发性视神经炎而无法用其它病因解释即应考虑AON。随诊过程中,必须留意全身症状并重复进行实验室检查,一旦其临床表现符合已知的自身免疫性疾病或胶原血管疾病(CVD)诊断标准,AON诊断将不再成立。部分找不到病因的视神经病变患者,特别是双眼发病或复发者,可以行皮肤活检辅助诊断。治疗AON的药物包括糖皮质激素、苯丁酸氮芥、环磷酰胺、甲氨喋呤、硫唑嘌呤、麦考酚酸吗乙酯及静脉注射免疫球蛋白等,但由于AON病例较为少见,目前还难以客观评价具体药物疗效。

    Release date:2016-09-02 05:41 Export PDF Favorites Scan
  • 脑动静脉畸形栓塞术后单眼突发失明一例

    Release date:2016-09-02 05:42 Export PDF Favorites Scan
  • 非动脉炎性前部缺血性视神经病变发病相关因素及治疗

    非动脉炎性前部缺血性视神经病变(nonarteritic anterior ischemic optic neuropathy,NAION)是一种多因素性眼病,与众多全身和局部因素有关。全身因素中,高血压,夜间低血压,糖尿病,失血,血流变性异常等较为常见;眼局部因素主要与视盘解剖特征,眼压和屈光状态有关。在全身和局部各种因素共同作用下,睫状后动脉病变导致视盘和部分筛板后视神经缺血性损害是其发病的基础。尽可能针对各种相关因素以预防其发生和减轻病变程度至关重要,视不同情况可分别使用全身皮质类固醇,左旋多巴与卡比多巴,阿斯匹林,血液透析,高压氧,视神经鞘减压术等进一步治疗。 (中华眼底病杂志,1999,15:125-127)

    Release date:2016-09-02 06:07 Export PDF Favorites Scan
  • 蝶窦及筛窦囊肿致压迫性视神经病变一例

    Release date: Export PDF Favorites Scan
  • Protection of retinal ganglion cells from optic nerve injury by human umbilical cord blood stem cells transplantation

    ObjectiveTo observe the protective effect of human umbilical cord blood stem cells (hUCBSC) transplantation on retinal ganglion cells (RGC) after optic nerve injury. Method48 adult Sprague-Dawley rats were randomly divided into group A and B, therefore 24 rats in each group. Calibrated optic nerve crush injury model was induced in the left eyes, the right eyes served as a control. Medicine was injected at seventh day after optic nerve injury. PBS was injected into the eyes of Group A rats by peribulbar injection. The hUCBSCs were injected into the eyes of Group B rats by peribulbar injection. Seven days before sacrifice, 5% fluorogold was injected into superior colliculi bilaterally. At 7, 14, 21, 28 days after labeled, retinal flat mounts were observed under fluorescence microscope and optical microscope to investigate the morphological and RGC changes in density during retinal degeneration. ResultsThe RGC number showed a tendency to decline gradually along with increases of the time in two groups, but the trend of decrease of Group B was evidently slower than that of Group A. The RGC number of the injury eye were less than the control eye in Group A and B (t=3.24, 3.15; P < 0.05). At 7, 14, 21, 28 days after labeled, the RGC number (t=4.78, 4.70, 3.98, 3.27; P < 0.05) and labeled RGC rate (t=4.39, 4.21, 4.36, 5.07; P < 0.05) in group B were more than those in group A. After optic nerve injury, there was karyopycnosis on ganglion cell layer of retina, thinning on each layer of retina, derangement of cell and decrease in RGC. There was different degree of the above change in different time after optic nerve injury. There were the swelling, the hemorrhage, derangement of spongiocyte and the denaturation like vacuole in the spot of optic nerve injury. Moreover, they were aggravating with increases of the time after optic nerve injury. There was no pathological changes in normal eyes. ConclusionThe hUCBSC can increase the survival rate of the RGC and can rescue and(or) restore the injujed RGC after transplanted into body of optic nerve crush rat model by peribulbar injection.

    Release date: Export PDF Favorites Scan
  • The role of ras homolog family/ras homolog family kinase signaling pathway and its inhibitors in the optic nerve disease

    Ras homolog family (Rho)/ Rho-associated coiled-coil kinase (ROCK) signaling pathway widely exists in human and mammal cells, which is closely related to inhibition of repair after optic nerve damage. The expression level of Rho/ROCK signaling pathway-related proteins is up-regulated in glaucoma, and related with the death of retinal ganglionic cell (RGC) and the axon activity. ROCK inhibitors can protect the surviving RGC and promote axon extension with a dose-dependent manner. ROCK inhibitors also can inhibit glial scar formation, lower intraocular pressure and inhibit inflammatory response to some degrees. Rho/ROCK signaling pathway correlates with the optic nerve disease progression, and ROCK inhibitors hope to become a new therapeutic drug.

    Release date:2017-09-19 03:09 Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content